vTv Therapeutics (VTVT) Leases (2019 - 2025)
vTv Therapeutics' Leases history spans 9 years, with the latest figure at $24000.0 for Q3 2025.
- For Q3 2025, Leases fell 84.62% year-over-year to $24000.0; the TTM value through Sep 2025 reached $24000.0, down 84.62%, while the annual FY2024 figure was $125000.0, 48.77% down from the prior year.
- Leases for Q3 2025 was $24000.0 at vTv Therapeutics, down from $58000.0 in the prior quarter.
- Across five years, Leases topped out at $464000.0 in Q1 2021 and bottomed at $24000.0 in Q3 2025.
- The 5-year median for Leases is $299000.0 (2023), against an average of $270526.3.
- The largest annual shift saw Leases fell 12.29% in 2021 before it tumbled 84.62% in 2025.
- A 5-year view of Leases shows it stood at $402000.0 in 2021, then dropped by 13.18% to $349000.0 in 2022, then plummeted by 30.09% to $244000.0 in 2023, then crashed by 48.77% to $125000.0 in 2024, then tumbled by 80.8% to $24000.0 in 2025.
- Per Business Quant, the three most recent readings for VTVT's Leases are $24000.0 (Q3 2025), $58000.0 (Q2 2025), and $92000.0 (Q1 2025).